AI-generated summary
The authors studied 27 patients with Alzheimer-type dementia who received morning bright light therapy for four weeks, measuring circadian rhythms by actigraphy and cognition with the MMSE and ADAS scales. They report improved circadian rhythm and better MMSE and ADAS scores, with the clearest gains in people with questionable or mild dementia. Because the abstract reports no control group, the findings are open to limits such as small sample size.
- Participants
- 27
- Who or what was studied
- Patients with Alzheimer-type dementia, grouped by severity (questionable/mild and moderate/severe)
- Limits stated in the abstract
- The abstract reports a small single-arm sample of 27 patients with no control group and does not report wavelengths or statistical details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jstage.jst.go.jp.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dementia, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.